A 52-year-old woman presents with proximal muscle weakness, morning stiffness and symmetrical swelling of the MCP and PIP joints. Rheumatoid factor and anti-CCP antibodies are positive. According to Australian inflammatory arthritis guidelines, what is the preferred initial disease-modifying treatment?